Literature DB >> 7630722

Use of oligonucleotides to define the site of interstrand cross-links induced by Adriamycin.

S M Cutts1, D R Phillips.   

Abstract

It has been known for several years that Adriamycin forms adducts and interstrand cross-links when reacted for long periods of time with bacterial and mammalian DNA in vitro, with the cross-link being restricted to 2 bp elements containing GpC sequences. The self-complementary 20mer deoxyoligonucleotide TA4T4GCA4T4A has been used in this study as a model of the apparent G-G cross-linking site at GpC sequences. The rate of formation of cross-links, as well as the dependence on both Adriamycin and Fe(III) concentration, were similar with this oligonucleotide as compared with calf thymus DNA. The cross-linking was demonstrated on both denaturing and non-denaturing sequencing gels. The half-life of the G-G cross-link was 40 h, consistent with that implied with high molecular weight, heterogeneous sequence DNA. Exonuclease III digests of adducts formed with 20mer deoxyoligonucleotides containing single, central G-G, G-I and I-I potential cross-links revealed that a guanine residue is required at both ends of the cross-link. No cross-linking was observed with a similar oligonucleotide containing only a single central (G.C) bp.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630722      PMCID: PMC307050          DOI: 10.1093/nar/23.13.2450

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

Review 1.  Overview of enzyme systems involved in bio-reduction of drugs and in redox cycling.

Authors:  H Kappus
Journal:  Biochem Pharmacol       Date:  1986-01-01       Impact factor: 5.858

2.  Binding of [14C]-adriamycin to cellular macromolecules in vivo.

Authors:  B K Sinha; R H Sik
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

3.  Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA.

Authors:  B K Sinha; C F Chignell
Journal:  Chem Biol Interact       Date:  1979-12       Impact factor: 5.192

4.  Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding.

Authors:  B K Sinha; J L Gregory
Journal:  Biochem Pharmacol       Date:  1981-09-15       Impact factor: 5.858

5.  NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.

Authors:  N R Bachur; S L Gordon; M V Gee; H Kon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

6.  Interstrand DNA crosslinking induced by anthracyclines in tumour cells.

Authors:  A Skladanowski; J Konopa
Journal:  Biochem Pharmacol       Date:  1994-06-15       Impact factor: 5.858

7.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

Authors:  K M Tewey; T C Rowe; L Yang; B D Halligan; L F Liu
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

8.  Adriamycin and daunomycin induce interstrand DNA crosslinks in Hela S3 Cells.

Authors:  J Konopa
Journal:  Biochem Biophys Res Commun       Date:  1983-02-10       Impact factor: 3.575

9.  Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.

Authors:  M C Willingham; M M Cornwell; C O Cardarelli; M M Gottesman; I Pastan
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

10.  Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B.

Authors:  R L Petrusek; G L Anderson; T F Garner; Q L Fannin; D J Kaplan; S G Zimmer; L H Hurley
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

View more
  5 in total

1.  An in vitro transcription assay for probing drug-DNA interactions at individual drug sites.

Authors:  D R Phillips; C M Cullinane; D M Crothers
Journal:  Mol Biotechnol       Date:  1998-08       Impact factor: 2.695

2.  A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues.

Authors:  Andrew T Lucas; Sara K O'Neal; Charlene M Santos; Taylor F White; William C Zamboni
Journal:  J Pharm Biomed Anal       Date:  2015-11-28       Impact factor: 3.935

3.  Characterization of covalent adriamycin-DNA adducts.

Authors:  S M Zeman; D R Phillips; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

4.  Remote loading of doxorubicin into liposomes by transmembrane pH gradient to reduce toxicity toward H9c2 cells.

Authors:  Mohamed Alyane; Gillian Barratt; Mesbah Lahouel
Journal:  Saudi Pharm J       Date:  2015-03-14       Impact factor: 4.330

5.  Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.

Authors:  Kate E Coldwell; Suzanne M Cutts; Ted J Ognibene; Paul T Henderson; Don R Phillips
Journal:  Nucleic Acids Res       Date:  2008-07-16       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.